齐默巴奥米特控股 ZBH 深 沪
等待开盘 10-07 09:30:00 美东时间
98.83
-1.950
-1.93%
华盛通- 最 高101.31
- 今 开101.03
- 成交量 106.55万股
- 最 低 98.78
- 昨 收 100.78
- 总市值 195.68亿
- 52周最高 113.96
- 市盈率 静 22.30
- 换手率 0.54%
- 52周最低 88.74
- 委 比 72.73%
- 总股本 1.98亿
- 历史最高 172.24
- 量 比 1.08
- 振 幅 2.51%
- 历史最低 31.94
- 每 手 1
- 风险率 7.93%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Zimmer Biomet Secures PMDA Japan Approval For iTaperloc Complete And iG7 Hip Systems, Orthopedic Implants With Iodine Anti-Bacterial Technology
iTaperloc® Complete and iG7™ Hip System with Iodine Technology inhibits bacterial adhesion and prevents biofilm formation on the implant surface to help address the issue of Periprosthetic Joint
09-26 04:33
美股大行评级 | 潜在涨幅302.68%！Maxim Group上调T Stamp目标价至12美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持T Stamp"买入"评级，目标价从8美元升至12美元；Maxim Group：维持Rezolute"买入"评级，目标价从15美元升至20美元
09-22 18:44
美股大行评级 | 上调！CrowdStrike、Lyft、MongoDB、Roivant等多只热门股获大行齐上调目标价
今日重点评级关注：Needham：上调爱美医疗评级至"买入"，目标价14美元；高盛：维持Roivant Sciences"买入"评级，目标价从20美元升至24美元
09-19 09:18
Rothschild & Co Initiates Coverage On Zimmer Biomet Holdings with Buy Rating, Announces Price Target of $130
Rothschild & Co analyst Ed Ridley-Day initiates coverage on Zimmer Biomet Holdings (NYSE:ZBH) with a Buy rating and announces Price Target of $130.
09-18 23:10
美股盘后 | 齐默巴奥米特控股涨3.96%，Sayona Mining Limited Unsponsored ADR涨2.81%
齐默巴奥米特控股涨3.96%；Sayona Mining Limited Unsponsored ADR涨2.81%；艺电涨2.67%
09-17 06:11
Zimmer Biomet Issues CHF 600 Million Debt Securities
Zimmer Biomet Holdings ( ($ZBH) ) has shared an announcement. On September 4, 2...
09-05 04:53
Zimmer Biomet declares $0.24 dividend
Zimmer Biomet (NYSE:ZBH) declares $0.24/share quarterly dividend, in line with previous. Forward yield 0.89% Payable Oct. 31; for shareholders of record Sept. 30; ex-div Sept. 30. See ZBH Dividend Sco...
08-27 19:08
Zimmer Biomet to Present at the Annual Morgan Stanley Healthcare Conference
WARSAW, Ind., Aug. 25, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the Annua...
08-25 19:30
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
A Glimpse Into The Expert Outlook On Zimmer Biomet Holdings Through 5 Analysts
Zimmer Biomet Holdings (NYSE:ZBH) underwent analysis by 5 analysts in the last ...
08-09 05:02
